Literature DB >> 3368993

Treatment of decompression sickness with a perfluorocarbon emulsion (FC-43).

B D Spiess1, R J McCarthy, K J Tuman, A W Woronowicz, K A Tool, A D Ivankovich.   

Abstract

Decompression sickness is caused by the production of tissue and blood stream inert gas bubbles. Perfluorocarbon emulsions (PFC) have enhanced O2 and N2 solubilities as well as a small particle size as properties. The effects of treatment with a PFC (FC-43) and 100% oxygen on decompression sickness were investigated in 24 Sprague-Dawley rats compressed to 6.8 ATA and rapidly decompressed. Survival in animals receiving PFC and 100% oxygen was significantly longer (P = 0.01) than in those receiving a 6% hetastarch (H) treatment. The PFC survivors at 24 h did not demonstrate any neurologic deficits, whereas the 1 H animal surviving at 24 h was ataxic and not eating. Those animals who died most often did so within minutes after decompression, suggesting a hemodynamic demise. We conclude that PFC treatment when coupled with 100% oxygen breathing provides both hemodynamic and neurologic protection from decompression sickness.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3368993

Source DB:  PubMed          Journal:  Undersea Biomed Res        ISSN: 0093-5387


  3 in total

Review 1.  Decompression sickness and arterial gas embolism in sports scuba divers.

Authors:  D F Gorman
Journal:  Sports Med       Date:  1989-07       Impact factor: 11.136

2.  Treatment of micro air bubbles in rat adipose tissue at 25 kPa altitude exposures with perfluorocarbon emulsions and nitric oxide.

Authors:  Thomas Randsøe; O Hyldegaard
Journal:  Eur J Appl Physiol       Date:  2013-10-25       Impact factor: 3.078

Review 3.  Perfluorocarbons for the treatment of decompression illness: how to bridge the gap between theory and practice.

Authors:  Dirk Mayer; Katja Bettina Ferenz
Journal:  Eur J Appl Physiol       Date:  2019-11-04       Impact factor: 3.078

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.